Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Gold Nanoparticles Crossing Blood-Brain Barrier Prevent HSV-1 Infection and Reduce Herpes Associated Amyloid-βsecretion.

I RI, Mj S, R G, Fj M, Mj B, Ma MF.

J Clin Med. 2020 Jan 7;9(1). pii: E155. doi: 10.3390/jcm9010155.

2.

Anionic Carbosilane Dendrimers Destabilize the GP120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion.

Guerrero-Beltran C, Rodriguez-Izquierdo I, Serramia MJ, Araya-Durán I, Márquez-Miranda V, Gomez R, de la Mata FJ, Leal M, González-Nilo F, Muñoz-Fernández MA.

Bioconjug Chem. 2018 May 16;29(5):1584-1594. doi: 10.1021/acs.bioconjchem.8b00106. Epub 2018 Mar 30.

PMID:
29570280
3.

Study of non-covalent interactions on dendriplex formation: Influence of hydrophobic, electrostatic and hydrogen bonds interactions.

Sánchez-Milla M, Pastor I, Maly M, Serramía MJ, Gómez R, Sánchez-Nieves J, Ritort F, Muñoz-Fernández MÁ, de la Mata FJ.

Colloids Surf B Biointerfaces. 2018 Feb 1;162:380-388. doi: 10.1016/j.colsurfb.2017.12.009. Epub 2017 Dec 8.

PMID:
29241096
4.

Improved Efficiency of Ibuprofen by Cationic Carbosilane Dendritic Conjugates.

Perisé-Barrios AJ, Fuentes-Paniagua E, Sánchez-Nieves J, Serramía MJ, Alonso E, Reguera RM, Gómez R, de la Mata FJ, Muñoz-Fernández MÁ.

Mol Pharm. 2016 Oct 3;13(10):3427-3438. Epub 2016 Sep 2.

PMID:
27533491
5.

HIV-1 increases TLR responses in human primary astrocytes.

Serramía MJ, Muñoz-Fernández MÁ, Álvarez S.

Sci Rep. 2015 Dec 16;5:17887. doi: 10.1038/srep17887.

6.

Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1.

Martínez-Bonet M, Clemente MI, Serramía MJ, Muñoz E, Moreno S, Muñoz-Fernández MÁ.

Sci Rep. 2015 Nov 13;5:16445. doi: 10.1038/srep16445.

7.

Prevention vaginally of HIV-1 transmission in humanized BLT mice and mode of antiviral action of polyanionic carbosilane dendrimer G2-S16.

Sepúlveda-Crespo D, Serramía MJ, Tager AM, Vrbanac V, Gómez R, De La Mata FJ, Jiménez JL, Muñoz-Fernández MÁ.

Nanomedicine. 2015 Aug;11(6):1299-308. doi: 10.1016/j.nano.2015.04.013. Epub 2015 May 8.

PMID:
25959924
8.

Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission.

Sepúlveda-Crespo D, Sánchez-Rodríguez J, Serramía MJ, Gómez R, De La Mata FJ, Jiménez JL, Muñoz-Fernández MÁ.

Nanomedicine (Lond). 2015;10(6):899-914. doi: 10.2217/nnm.14.79.

PMID:
25867856
9.

In vivo delivery of siRNA to the brain by carbosilane dendrimer.

Serramía MJ, Álvarez S, Fuentes-Paniagua E, Clemente MI, Sánchez-Nieves J, Gómez R, de la Mata J, Muñoz-Fernández MÁ.

J Control Release. 2015 Feb 28;200:60-70. doi: 10.1016/j.jconrel.2014.12.042. Epub 2015 Jan 2.

PMID:
25559178
10.

Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?

Martínez-Bonet M, Clemente MI, Serramía MJ, Moreno S, Muñoz E, Muñoz-Fernández MA.

J Virus Erad. 2015 Jul 1;1(3):148-52. Review.

11.

Prostaglandin E2 reduces the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer.

Clemente MI, Álvarez S, Serramía MJ, Martínez-Bonet M, Muñoz-Fernández MÁ.

PLoS One. 2014 Feb 25;9(2):e85230. doi: 10.1371/journal.pone.0085230. eCollection 2014.

12.

A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe).

de Jose MI, Jiménez de Ory S, Espiau M, Fortuny C, Navarro ML, Soler-Palacín P, Muñoz-Fernandez MA; working groups of CoRISpe and HIV HGM BioBank.

BMC Infect Dis. 2013 Jan 2;13:2. doi: 10.1186/1471-2334-13-2.

13.

Validation of a generation 4 phosphorus-containing polycationic dendrimer for gene delivery against HIV-1.

Briz V, Serramía MJ, Madrid R, Hameau A, Caminade AM, Majoral JP, Muñoz-Fernández MA.

Curr Med Chem. 2012;19(29):5044-51.

PMID:
22963636
14.

Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile.

Chonco L, Pion M, Vacas E, Rasines B, Maly M, Serramía MJ, López-Fernández L, De la Mata J, Alvarez S, Gómez R, Muñoz-Fernández MA.

J Control Release. 2012 Aug 10;161(3):949-58. doi: 10.1016/j.jconrel.2012.04.050. Epub 2012 May 28.

PMID:
22652549
15.

Erratum: changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16.

Gras R, Almonacid L, Ortega P, Serramia MJ, Gomez R, de la Mata FJ, Lopez-Fernandez LA, Muñoz-Fernandez MA.

Pharm Res. 2011 Mar;28(3):683-7. doi: 10.1007/s11095-010-0328-y. No abstract available.

PMID:
21116693
16.

Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer.

Pion M, Serramia MJ, Diaz L, Bryszewska M, Gallart T, García F, Gómez R, de la Mata FJ, Muñoz-Fernandez MÁ.

Biomaterials. 2010 Nov;31(33):8749-58. doi: 10.1016/j.biomaterials.2010.07.093. Epub 2010 Sep 15.

PMID:
20832111
17.

Gene therapy in HIV-infected cells to decrease viral impact by using an alternative delivery method.

Gonzalo T, Clemente MI, Chonco L, Weber ND, Díaz L, Serramía MJ, Gras R, Ortega P, de la Mata FJ, Gómez R, Lopez-Fernández LA, Muñoz-Fernández MA, Jiménez JL.

ChemMedChem. 2010 Jun 7;5(6):921-9. doi: 10.1002/cmdc.201000029.

PMID:
20414916
18.

Non-steroidal anti-inflammatory drugs increase the antiretroviral activity of nucleoside reverse transcriptase inhibitors in HIV type-1-infected T-lymphocytes: role of multidrug resistance protein 4.

Clemente MI, Alvarez S, Serramía MJ, Turriziani O, Genebat M, Leal M, Fresno M, Muñoz-Fernández MA.

Antivir Ther. 2009;14(8):1101-11. doi: 10.3851/IMP1468.

PMID:
20032540
19.

The Spanish HIV BioBank: a model of cooperative HIV research.

García-Merino I, de Las Cuevas N, Jiménez JL, Gallego J, Gómez C, Prieto C, Serramía MJ, Lorente R, Muñoz-Fernández MA; Spanish HIV BioBank.

Retrovirology. 2009 Mar 9;6:27. doi: 10.1186/1742-4690-6-27.

20.

Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16.

Gras R, Almonacid L, Ortega P, Serramia MJ, Gomez R, de la Mata FJ, Lopez-Fernandez LA, Muñoz-Fernandez MA.

Pharm Res. 2009 Mar;26(3):577-86. doi: 10.1007/s11095-008-9776-z. Epub 2008 Nov 25. Erratum in: Pharm Res. 2011 Mar;28(3):683-7.

PMID:
19034630

Supplemental Content

Loading ...
Support Center